Comparative cost-effectiveness of oral vs. transdermal contraceptive methods.

被引：0
|
作者：
Gajria, K. L.
Wallenstein, G. V.
Chang, J.
机构：
[1] Bayer Healthcare Pharmaceut, Wayne, NJ USA
[2] QualityMetric Inc, Lincoln, RI USA
来源：
FERTILITY AND STERILITY | 2007年 / 88卷
关键词：
D O I：
10.1016/j.fertnstert.2007.07.883
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of oral and transdermal contraceptive methods
    Gajria, K. L.
    Wallenstein, G., V
    Hagan, M. A.
    VALUE IN HEALTH, 2007, 10 (03) : A156 - A156
  • [2] Cost-effectiveness of oral and transdermal contraceptives
    Zaliska, O.
    Pushak, K.
    VALUE IN HEALTH, 2008, 11 (03) : A247 - A248
  • [3] Bayesian cost-effectiveness analysis: Illustration of methods.
    Fryback, DG
    Chinnis, JO
    Uvila, J
    MEDICAL DECISION MAKING, 1998, 18 (04) : 484 - 484
  • [4] Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies
    Sharaf, Ravi N.
    Ladabaum, Uri
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (01): : 120 - 132
  • [5] Comparative Effectiveness and Cost-effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies
    Sharaf, Ravi
    Ladabaum, Uri
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S565 - S565
  • [6] Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables
    Kluft, Cornelis
    Meijer, Piet
    LaGuardia, Katherine D.
    Fisher, Alan C.
    CONTRACEPTION, 2008, 77 (02) : 77 - 83
  • [7] European cost-effectiveness of oral anticoagulation vs. aspirin after myocardial infarction
    Gianetti, J
    Gensini, GF
    DeCaterina, R
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS332 - PS332
  • [8] Cost-effectiveness of detoxification vs. buprenorphine in pregnancy
    Willey, Alicia S.
    Walker, Allison R.
    Toffey, David E.
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S490 - S490
  • [9] Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Wiwanitkit, Viroj
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (11) : 1675 - 1675
  • [10] Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Viroj Wiwanitkit
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 1675 - 1675
12345